BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86%
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

BRAIN Biotech AG
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BRAIN Biotech AG
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Long-Term Investments
€1.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Long-Term Investments
€1.1B
CAGR 3-Years
160%
CAGR 5-Years
9%
CAGR 10-Years
18%
Evonik Industries AG
XETRA:EVK
Long-Term Investments
€552m
CAGR 3-Years
-5%
CAGR 5-Years
16%
CAGR 10-Years
1%
Covestro AG
XETRA:1COV
Long-Term Investments
€347m
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Long-Term Investments
€132k
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Long-Term Investments
€634.1m
CAGR 3-Years
80%
CAGR 5-Years
109%
CAGR 10-Years
N/A
No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap
75.2m EUR
Industry
Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN Intrinsic Value
5.16 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is BRAIN Biotech AG's Long-Term Investments?
Long-Term Investments
1.1m EUR

Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Long-Term Investments amounts to 1.1m EUR.

Back to Top